An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
Public ClinicalTrials.gov record NCT01560637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is an international, multi-center, open-label study designed to provide oral treprostinil (UT-15C) to eligible subjects with pulmonary arterial hypertension who have completed the TDE-PH-310 study. The purpose of this study is to assess the long-term safety of UT-15C and to assess the effects of long-term treatment with UT-15C on exercise capacity.
Study identification
- NCT ID
- NCT01560637
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 471 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 11, 2013 (Actual)
- Primary completion
- Aug 12, 2021 (Actual)
- Completion
- Aug 12, 2021 (Actual)
- Last update posted
- Jun 2, 2022
2013 – 2021
United States locations
- U.S. sites
- 38
- U.S. states
- 23
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Pulmonary Specialists, Ltd. | Phoenix | Arizona | 85012 | — |
| University of Arizona | Tucson | Arizona | 85724 | — |
| University of California, San Francisco-Fresno | Fresno | California | 93701 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90211 | — |
| University of California-Davis Medical Group, Advanced Lung Disease/Transplant Program | Sacramento | California | 95817 | — |
| David Geffen School of Medicine | Torrance | California | 90502 | — |
| University of Colorado Hospital | Aurora | Colorado | 80045 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| University of Florida College of Medicine Jacksonville- Division of Pulmonary & Critical Medicine | Jacksonville | Florida | 32209 | — |
| Cleveland Clinic Florida | Weston | Florida | 33331 | — |
| Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Augusta University | Augusta | Georgia | 30912 | — |
| Piedmont - Georgia Lung Associates | Austell | Georgia | 30106 | — |
| HeartCare Midwest | Peoria | Illinois | 61614 | — |
| Indiana University Hospital | Carmel | Indiana | 46032 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 55242 | — |
| Kentuckiana Pulmonary Associates | Louisville | Kentucky | 40202 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Beaumont Health | Troy | Michigan | 48085 | — |
| Nebraska Medical Center | Omaha | Nebraska | 68198-5990 | — |
| Newark Beth Israel Medical Center | Newark | New Jersey | 07112 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Asheville Cardiology Associates | Asheville | North Carolina | 28803 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| University Hospital | Cleveland | Ohio | 44106 | — |
| Ohio State University | Columbus | Ohio | 43321 | — |
| Oregon Health and Science University | Portland | Oregon | 97201-3098 | — |
| Legacy Research Institute | Portland | Oregon | 97210 | — |
| Perelman Center for Advanced Medicine, University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh Medical Center - Presbyterian Cardiovascular Institute | Pittsburgh | Pennsylvania | 15213 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| Sentara Cardiovascular Research Institute | Norfolk | Virginia | 23507 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| Aurora Saint Luke's Medical Center | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 115 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01560637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2022 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01560637 live on ClinicalTrials.gov.